Smartwatch May Track AD Status in Children - Takeaways - MDSpire
From the Journals

Smartwatch May Track AD Status in Children

Wearable-derived scratching measures align with disease activity and short-term treatment response in pediatric patients with atopic dermatitis.

  • By

  • Andrea Surnit

  • May 5, 2026

  • 3 min

Share

  • 1

    Study assessed smartwatch-measured scratching in pediatrics.

  • 2

    Involved 50 subjects aged 4-15 with atopic dermatitis.

  • 3

    Metrics included scratch count, duration, and burden.

  • 4

    Moderate correlation with clinical severity and improvement observed.

  • 5

    The scratch burden index had strong predictive abilities.

  • 6

    Study highlights limitations including small sample size and lack of causal inference.

  • 7

    Further validation needed before clinical application.

Original Source(s)

Smartwatch May Track AD Status in Children

  • by Andrea Surnit

  • May 5, 2026

Related Content

AAP Updates Pediatric Office Emergency Readiness

Guidance addresses office readiness, recommended equipment and medications, and team communication processes for infrequent but high-acuity emergencies.

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

FDA Reports Results of Nationwide Infant Formula Testing

Federal testing survey examines chemical contaminant profiles across widely used products